2018
DOI: 10.1039/c7bm01114h
|View full text |Cite
|
Sign up to set email alerts
|

Light-triggered release of drug conjugates for an efficient combination of chemotherapy and photodynamic therapy

Abstract: Herein, we present a series of light-triggered porphyrin-based polymeric drug conjugates PSDTD-m for combined chemo-photodynamic therapy of cancer. The controlled release of a drug through a ROS-cleavable linker combined with photodynamic therapy showed enhanced anticancer efficacy, proving the effectiveness of this light triggered smart nanocarrier platform for enhancing the therapy efficacy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 28 publications
0
12
0
Order By: Relevance
“…Additionally, pullulan acts as a natural ligand for the asialoglyco protein receptor (ASGPR) [224], which is often overexpressed by HCC cells. In 2018, Liu and co-workers [225] reported a light-responsive porphyrin-dextranbased polymeric DOX conjugate to control DOX release through ROS-cleavable linker combined with PDT. In 2009, Khdair and co-workers [226] constructed aerosol OT (AOT)-alginate nanoparticles for the co-delivery of DOX and methylene blue (a photo activated dye by 665 nm wavelength) in drug-resistant NCI/ADR-RES cells (a multidrug-resistant cell line in ovarian cancer).…”
Section: Application Of Polymers In Pdtmentioning
confidence: 99%
“…Additionally, pullulan acts as a natural ligand for the asialoglyco protein receptor (ASGPR) [224], which is often overexpressed by HCC cells. In 2018, Liu and co-workers [225] reported a light-responsive porphyrin-dextranbased polymeric DOX conjugate to control DOX release through ROS-cleavable linker combined with PDT. In 2009, Khdair and co-workers [226] constructed aerosol OT (AOT)-alginate nanoparticles for the co-delivery of DOX and methylene blue (a photo activated dye by 665 nm wavelength) in drug-resistant NCI/ADR-RES cells (a multidrug-resistant cell line in ovarian cancer).…”
Section: Application Of Polymers In Pdtmentioning
confidence: 99%
“…As a commonly used therapy strategy for cancer treatments, chemotherapy helps to kill cancer cells effectively, but simultaneously causes strong toxicity to normal cells, tissues, and organs . Therefore, it is of great importance to reduce the side effects of chemotherapy through controllable release of chemotherapy drugs . Recently, the strategy of combining chemotherapy with PTT has significantly enhanced cancer therapeutic efficiency and reduced the side effects caused by rapid release of chemotherapy drugs .…”
Section: Applications Of Graphitic Nanocapsulesmentioning
confidence: 99%
“…18 Many powerful nanoformulations have been developed by sophisticated design and fabrication, which involves combining many functional molecules to satisfy all the demands. 19–22 However, to our knowledge, the principal characteristics of the nanoformulations approved by the Food and Drug Administration (FDA), such as those of liposomal doxorubicin, albumin-based nanoparticles and paclitaxel-loaded micelles, are simple and have unambiguous structure. 23,24 Despite the remarkable advances achieved in the recent few decades, there are no multifunctional nanotechnology therapeutic products clinically approved by the FDA for cancer therapy so far.…”
Section: Introductionmentioning
confidence: 99%